Psychologists in Barboursville, WV Accepting Medicare
8 Psychologists found. Showing 1 - 8
 Mary Chaney, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 River Rd, Barboursville, WV 25504 Phone: 304-302-2467 Fax: 304-302-0215 |
Mrs. Jacqueline Michelle Mccord, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5974 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-6677 Fax: 304-736-6677 |
Ms. Pamela Gail Newlon, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6168 Edens Branch Rd, Barboursville, WV 25504 Phone: 304-733-0426 |
Janet Weekley Adkins, M.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 6351 Us Route 60 E, Johnson Plaza, Suite 2a, Barboursville, WV 25504 Phone: 304-522-9555 Fax: 304-522-9555 |
Mrs. Teresa C Copley, MA MS Psychologist Medicare: Medicare Enrolled Practice Location: 6349 Us Route 60 E, Ste 4, Barboursville, WV 25504 Phone: 304-733-7642 Fax: 304-721-8889 |
Emily Engelland Wilson, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 River Rd, Barboursville, WV 25504 Phone: 304-302-2467 Fax: 304-302-0215 |
Wendy Manns, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5974 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-6677 |
Elise Edwards, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5974 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-6677 |
News Archive
New combined imaging promises insights into multiple sclerosis
Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
Vitae earns $14M milestone payment from Boehringer Ingelheim
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
Researchers make significant advance in treatment of bowel cancer
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
› Verified 6 days ago
Pharmacists
Counselors
Dentists
Psychologists
Clinical Social Workers
Occupational Therapists